Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 646 clinical trials
Featured trial
Heart Valve Disease – Aortic and Mitral

Study Description: Multi-center, international, prospective, randomized, interventional, pre-market study. Patients will be seen at pre and post-procedure, discharge, 30 days, 6 months, 1 year, 18 months, and annually through 10 years. Randomly assigned (50% to either group) Treatment of Aortic Stenosis with either Transcatheter Aortic Valve Replacement (TAVR) device or …

stenosis
aortic valve replacement
  • 799 views
  • 05 Feb, 2021
  • 1 location
Featured trial
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients with Non-Valvular Atrial Fibrillation (CHAMPION-AF)

K Antagonist Oral Anticoagulants (NOACs), in patients with non-valvular atrial fibrillation.Subjects will be randomized to either the WATCHMAN FLX Left Atrial Appendage

vascular disease
vitamin k antagonist
left atrial appendage closure
vitamin k
anticoagulants
  • 0 views
  • 18 Oct, 2021
  • 1 location
Featured trial
ENSURE-AF

ENSURE-AF

  • 83 views
  • 25 Mar, 2021
  • 1 location
Featured trial
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

  • 94 views
  • 25 Mar, 2021
  • 1 location
Featured trial
GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

  • 471 views
  • 08 Nov, 2020
  • 1 location
Featured trial
  • 89 views
  • 08 Nov, 2020
  • 1 location
Featured trial
BIO-AffectDX: Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System

The purpose of the BIO-AffectDX Study is to prospectively evaluate improvement from baseline in heart failure subjects with atrial fibrillation (AF) implanted with a two-lead CRT-DX system, with

persistent atrial fibrillation
heart failure
  • 0 views
  • 07 Jan, 2022
  • 1 location
Featured trial
Reveal

Reveal

  • 200 views
  • 25 Mar, 2021
  • 1 location
Featured trial
CONVERGE

CONVERGE

  • 1019 views
  • 23 Nov, 2020
  • 10 locations